Jacobson Kenneth A, Costanzi Stefano, Paoletta Silvia
Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-0810, USA.
Department of Chemistry and Center for Behavioral Neuroscience, American University, Washington, DC 20016, USA.
Trends Pharmacol Sci. 2014 Dec;35(12):658-63. doi: 10.1016/j.tips.2014.10.009. Epub 2014 Nov 14.
Since G protein-coupled receptors (GPCRs) belong to a very large superfamily of evolutionarily related receptors (>800 members in humans), and due to the rapid progress on their structural biology, they are ideal candidates for polypharmacology studies. Broad screening and bioinformatics/chemoinformatics have been applied to understanding off-target effects of GPCR ligands. It is now feasible to approach the question of GPCR polypharmacology using molecular modeling and the available X-ray GPCR structures. As an example, large and sterically constrained adenosine derivatives (potent adenosine receptor ligands with low conformational freedom and multiple extended substituents) were screened for binding at diverse receptors. Unanticipated off-target interactions, including at biogenic amine receptors, were then modeled using a structure-based approach to provide a consistent understanding of recognition. A conserved Asp in TM3 changed its role from counterion for biogenic amines to characteristic H-bonding to adenosine. The same systematic approach could potentially be applied to many GPCRs or other receptors using other sets of congeneric ligands.
由于G蛋白偶联受体(GPCRs)属于一个非常大的进化相关受体超家族(人类中有超过800个成员),并且由于其结构生物学的快速进展,它们是多药理学研究的理想候选者。广泛筛选和生物信息学/化学信息学已被用于理解GPCR配体的脱靶效应。现在,使用分子建模和可用的X射线GPCR结构来解决GPCR多药理学问题是可行的。例如,筛选了大的、空间受限的腺苷衍生物(具有低构象自由度和多个延伸取代基的强效腺苷受体配体)与多种受体的结合情况。然后使用基于结构的方法对意外的脱靶相互作用(包括与生物胺受体的相互作用)进行建模,以提供对识别的一致理解。跨膜螺旋3(TM3)中一个保守的天冬氨酸从生物胺的抗衡离子转变为与腺苷形成特征性氢键的角色。使用其他同类配体组,相同的系统方法可能潜在地应用于许多GPCR或其他受体。